about
Native functionality and therapeutic targeting of arenaviral glycoproteinsTherapeutic antibodies: current state and future trends--is a paradigm change coming soon?A case of Lassa fever: clinical and virological findings.Passive antibody administration (immediate immunity) as a specific defense against biological weapons.Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
P2860
Q26827679-5939FB98-06C7-4570-90EE-B565D48A43E5Q28728956-53A61D63-7868-483D-8CA6-38EEA7A03FC2Q34056433-A6365037-18E5-41D3-A1F8-D7D8F1B74F34Q34762095-D6E4C5F1-E48A-4E8C-856C-BE0D9BC90C1EQ35847032-DC8DC96D-4212-409D-B078-D7B813E4E7FAQ37083078-F5C332E5-4E9D-477F-98B5-FD406F97C1A0Q56552815-51EA6373-BC37-4E6D-853C-D32800836065
P2860
description
1977 nî lūn-bûn
@nan
1977 թուականին հրատարակուած գիտական յօդուած
@hyw
1977 թվականին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Lassa immune serum
@ast
Lassa immune serum
@en
Lassa immune serum
@nl
type
label
Lassa immune serum
@ast
Lassa immune serum
@en
Lassa immune serum
@nl
prefLabel
Lassa immune serum
@ast
Lassa immune serum
@en
Lassa immune serum
@nl
P2860
P1476
Lassa immune serum
@en
P2093
A J Clayton
P2860
P407
P577
1977-01-01T00:00:00Z